Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MICHELLE A PRUETT

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant

NPI
1538147533
CMS profile
11076719
Location
AUSTIN, TX

General Payments · PY2021–2024

$4,398.27

  • Reported across 171 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,434.67

37 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,434.67 37

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Medtronic, Inc. $310.46 2
Novo Nordisk AS $219.81 12
Amgen Inc. $165.81 3
Acerta Pharma LLC $160.64 5
ZIMVIE INC. $144.40 1
Nevro Corp. $144.22 3
Gilead Sciences, Inc. $109.01 1
ABBVIE INC. $72.41 4
PFIZER INC. $60.93 3
GlaxoSmithKline, LLC. $31.96 2
Lilly USA, LLC $15.02 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $1,122.97 64
PY2022 $861.71 37
PY2023 $978.92 33
PY2024 $1,434.67 37

Payment records · PY2024 (37)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $21.46 02/07/2024 Food and Beverage Undisputed 01/23/2026 1108044020 CMS
ABBVIE INC. $15.25 04/19/2024 Food and Beverage Undisputed 01/23/2026 1108044022 CMS
ABBVIE INC. $17.59 08/09/2024 Food and Beverage Undisputed 01/23/2026 1108044024 CMS
ABBVIE INC. $18.11 09/13/2024 Food and Beverage Undisputed 01/23/2026 1108044026 CMS
Amgen Inc. $135.96 05/14/2024 Food and Beverage Undisputed 01/23/2026 1117659670 CMS
Amgen Inc. $14.17 08/08/2024 Food and Beverage Undisputed 01/23/2026 1117659664 CMS
Amgen Inc. $15.68 10/18/2024 Food and Beverage Undisputed 01/23/2026 1117659666 CMS
AstraZeneca Pharmaceuticals LP $34.41 02/10/2024 Food and Beverage Undisputed 01/23/2026 1105573775 CMS
AstraZeneca Pharmaceuticals LP $13.19 03/29/2024 Food and Beverage Undisputed 01/23/2026 1105821063 CMS
AstraZeneca Pharmaceuticals LP $13.82 05/17/2024 Food and Beverage Undisputed 01/23/2026 1105717886 CMS
AstraZeneca Pharmaceuticals LP $84.51 07/11/2024 Food and Beverage Undisputed 01/23/2026 1104473824 CMS
AstraZeneca Pharmaceuticals LP $14.71 09/28/2024 Food and Beverage Undisputed 01/23/2026 1104609358 CMS
Gilead Sciences, Inc. $109.01 03/21/2024 Food and Beverage Undisputed 01/23/2026 1133721333 CMS
GlaxoSmithKline, LLC. $16.66 06/14/2024 Food and Beverage Undisputed 01/23/2026 1116088193 CMS
GlaxoSmithKline, LLC. $15.30 08/30/2024 Food and Beverage Undisputed 01/23/2026 1116075024 CMS
Lilly USA, LLC $15.02 03/12/2024 Food and Beverage Undisputed 01/23/2026 1135835392 CMS
Medtronic, Inc. $149.88 06/21/2024 Food and Beverage Undisputed 01/23/2026 1116959160 CMS
Medtronic, Inc. $160.58 08/06/2024 Food and Beverage Undisputed 01/23/2026 1116959162 CMS
Nevro Corp. $115.76 06/04/2024 Food and Beverage Undisputed 01/23/2026 1130777361 CMS
Nevro Corp. $11.97 08/16/2024 Food and Beverage Undisputed 01/23/2026 1130777363 CMS
Nevro Corp. $16.49 10/24/2024 Food and Beverage Undisputed 01/23/2026 1130777365 CMS
Novo Nordisk Inc $12.28 03/19/2024 Food and Beverage Undisputed 01/23/2026 1100245997 CMS
Novo Nordisk Inc $78.75 03/28/2024 Food and Beverage Undisputed 01/23/2026 1100259111 CMS
Novo Nordisk Inc $10.77 04/02/2024 Food and Beverage Undisputed 01/23/2026 1100420516 CMS
Novo Nordisk Inc $16.00 04/23/2024 Food and Beverage Undisputed 01/23/2026 1100615051 CMS
Novo Nordisk Inc $10.88 04/30/2024 Food and Beverage Undisputed 01/23/2026 1100262167 CMS
Novo Nordisk Inc $21.52 05/06/2024 Food and Beverage Undisputed 01/23/2026 1100301637 CMS
Novo Nordisk Inc $9.65 06/24/2024 Food and Beverage Undisputed 01/23/2026 1100244247 CMS
Novo Nordisk Inc $13.77 07/18/2024 Food and Beverage Undisputed 01/23/2026 1100225742 CMS
Novo Nordisk Inc $20.84 07/22/2024 Food and Beverage Undisputed 01/23/2026 1100433691 CMS
Novo Nordisk Inc $9.29 07/27/2024 Food and Beverage Undisputed 01/23/2026 1100529819 CMS
Novo Nordisk Inc $8.18 08/26/2024 Food and Beverage Undisputed 01/23/2026 1100495057 CMS
Novo Nordisk Inc $7.88 09/30/2024 Food and Beverage Undisputed 01/23/2026 1100323314 CMS
PFIZER INC. $25.29 01/20/2024 Food and Beverage Undisputed 01/23/2026 1131177493 CMS
PFIZER INC. $18.01 07/20/2024 Food and Beverage Undisputed 01/23/2026 1131759574 CMS
PFIZER INC. $17.63 11/09/2024 Food and Beverage Undisputed 01/23/2026 1132112885 CMS
ZIMVIE INC. $144.40 02/12/2024 Food and Beverage Undisputed 01/23/2026 1142580991 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.